A business in context
CORT research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-24 | Robb Gary Charles | G · Gift | Common Stock | 5000.0 | 0.0 |
| 2026-09-24 | Robb Gary Charles | G · Gift | Common Stock | 5000.0 | 0.0 |
| 2026-09-24 | Robb Gary Charles | G · Gift | Common Stock | 17100.0 | 0.0 |
| 2026-09-17 | Robb Gary Charles | M · Exercise / conversion | Common Stock | 17493.0 | 8.27 |
| 2026-09-17 | Robb Gary Charles | M · Exercise / conversion | Stock option (right to buy) | 17493.0 | 0.0 |
| 2026-09-16 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 296.0 | 100.82 |
| 2026-09-15 | WILSON JAMES N | S · Sale | Common Stock | 2800.0 | 111.7 |
| 2026-09-15 | WILSON JAMES N | S · Sale | Common Stock | 400.0 | 110.84 |
| 2026-09-15 | WILSON JAMES N | S · Sale | Common Stock | 6800.0 | 110.27 |
| 2026-09-14 | Lyon Joseph Douglas | M · Exercise / conversion | Common Stock | 2596.0 | 11.35 |
| 2026-09-14 | Lyon Joseph Douglas | S · Sale | Common Stock | 7812.0 | 113.32 |
| 2026-09-14 | Lyon Joseph Douglas | M · Exercise / conversion | Common Stock | 7404.0 | 13.56 |
| 2026-09-14 | Lyon Joseph Douglas | S · Sale | Common Stock | 2188.0 | 114.12 |
| 2026-09-14 | Lyon Joseph Douglas | M · Exercise / conversion | Stock option (right to buy) | 7404.0 | 0.0 |
| 2026-09-14 | Lyon Joseph Douglas | M · Exercise / conversion | Stock option (right to buy) | 2596.0 | 0.0 |
| 2026-09-02 | Maduck Sean | F · Tax / exercise payment | Common Stock | 117.0 | 113.38 |
| 2026-09-02 | Mokari Atabak | F · Tax / exercise payment | Common Stock | 102.0 | 113.38 |
| 2026-09-02 | Robb Gary Charles | F · Tax / exercise payment | Common Stock | 91.0 | 113.38 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 1225.0 | 115.44 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 5621.0 | 114.58 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 1606.0 | 113.72 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 1537.0 | 111.37 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 23770.0 | 110.7 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 23600.0 | 109.35 |
| 2026-09-02 | Vieira Roberto Wandenkolk | M · Exercise / conversion | Common Stock | 58333.0 | 21.63 |
| 2026-09-02 | Vieira Roberto Wandenkolk | F · Tax / exercise payment | Common Stock | 102.0 | 113.38 |
| 2026-09-02 | Vieira Roberto Wandenkolk | S · Sale | Common Stock | 974.0 | 112.4 |
| 2026-09-02 | Vieira Roberto Wandenkolk | M · Exercise / conversion | Stock option (right to buy) | 58333.0 | 0.0 |
| 2026-09-02 | Lyon Joseph Douglas | F · Tax / exercise payment | Common Stock | 72.0 | 113.38 |
| 2026-09-01 | Guyer William | A · Grant / award | Common Stock | 164.0 | 113.38 |
| 2026-09-01 | Guyer William | A · Grant / award | Common Stock | 164.0 | 0.0 |
| 2026-09-01 | Maduck Sean | S · Sale | Common Stock | 11730.0 | 113.94 |
| 2026-09-01 | Maduck Sean | A · Grant / award | Common Stock | 150.0 | 113.38 |
| 2026-09-01 | Maduck Sean | S · Sale | Common Stock | 2281.0 | 115.61 |
| 2026-09-01 | Maduck Sean | S · Sale | Common Stock | 10989.0 | 114.71 |
| 2026-09-01 | Maduck Sean | M · Exercise / conversion | Common Stock | 25000.0 | 8.27 |
| 2026-09-01 | Maduck Sean | A · Grant / award | Common Stock | 150.0 | 0.0 |
| 2026-09-01 | Maduck Sean | M · Exercise / conversion | Stock option (right to buy) | 25000.0 | 0.0 |
| 2026-09-01 | Mokari Atabak | A · Grant / award | Common Stock | 138.0 | 0.0 |
| 2026-09-01 | Mokari Atabak | A · Grant / award | Common Stock | 138.0 | 113.38 |
| 2026-09-01 | Robb Gary Charles | A · Grant / award | Common Stock | 164.0 | 113.38 |
| 2026-09-01 | Robb Gary Charles | A · Grant / award | Common Stock | 164.0 | 0.0 |
| 2026-09-01 | Vieira Roberto Wandenkolk | A · Grant / award | Common Stock | 138.0 | 0.0 |
| 2026-09-01 | Vieira Roberto Wandenkolk | A · Grant / award | Common Stock | 138.0 | 113.38 |
| 2026-09-01 | Lyon Joseph Douglas | A · Grant / award | Common Stock | 130.0 | 0.0 |
| 2026-09-01 | Lyon Joseph Douglas | A · Grant / award | Common Stock | 130.0 | 113.38 |
| 2026-08-26 | Park Kimberly | F · Tax / exercise payment | Common Stock | 3315.0 | 122.09 |
| 2026-08-26 | Park Kimberly | M · Exercise / conversion | Common Stock | 30000.0 | 13.49 |
| 2026-08-26 | Park Kimberly | S · Sale | Common Stock | 26685.0 | 122.55 |
| 2026-08-26 | Park Kimberly | M · Exercise / conversion | Stock Option (right to buy) | 30000.0 | 0.0 |
Identity & relationships
SEC issuer · 0001088856CORCEPT THERAPEUTICS INC
Search names and former names
View Wikidata identity and references ↗
- Corcept Therapeutics · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $675.04M | $725.06M |
| 2023-12-31 | $482.38M | $533.38M |
| 2022-12-31 | $401.86M | $462.59M |
| 2021-12-31 | $365.98M | $455.00M |
| 2020-12-31 | $353.87M | $460.70M |
| 2019-12-31 | $306.49M | $403.90M |
| 2018-12-31 | $251.25M | $337.11M |
| 2017-12-31 | $159.20M | $218.83M |